Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Opioid Settlements topic

No spam. Unsubscribe anytime.

Shiawassee County authorizes participation in Purdue/Sackler and manufacturer opioid settlements

Shiawassee County Board of Commissioners · August 13, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The board adopted Resolutions #25-08-14 and #25-08-15 to enter participation agreements for the Purdue/Sackler settlement and additional manufacturer settlements, authorizing a 50/50 allocation method between participating local governments and the State of Michigan and instructing counsel to vote on the county's behalf; motions passed 6-0.

The Shiawassee County Board of Commissioners voted on Aug. 13 to enter participation agreements in partial settlement of national opioid litigation, adopting two resolutions that authorize county participation and set an allocation method for settlement proceeds.

Resolution #25-08-14 authorizes the county to execute a Participation Agreement for the proposed Purdue/Sackler settlement and to enter a Michigan state-subdivision allocation agreement that would allocate funds 50/50 between participating local governments and the State of Michigan. The resolution states that the Sackler Family Defendants would pay $6.5 billion over 15 years under the proposed agreement and that the Purdue estate would contribute approximately $900 million; the resolution also authorizes the Weitz & Luxenberg law firm to vote on the county’s behalf in favor of Purdue’s bankruptcy plan.

The board also adopted Resolution #25-08-15 to authorize participation agreements for proposed settlements with multiple pharmaceutical manufacturers (Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun and Zydus). The resolution’s recital lists proposed payment amounts for each settling defendant (for example, Amneal is listed at $71,751,010 over ten years, Mylan at $284,447,916 over nine years, and other amounts as noted in the resolution). The resolutions state that a substantial portion of settlement payments will be dedicated to abatement and prevention strategies related to the opioid public nuisance and that several settlements include marketing and product restrictions for defendants.

Commissioner Garber moved and Commissioner Howard seconded adoption of the resolutions; both motions carried on recorded votes of six yeas and zero nays. The resolutions instruct county officials to execute the participation agreements (copies and specimen terms are referenced in the meeting record) and to execute a state-subdivision allocation agreement substantially similar to the proposed Exhibit B attachments.

The meeting record shows the county has previously executed participation agreements for Distributor, Janssen, Teva, Allergan, CVS, Walmart and Walgreens settlements. The resolutions point to the national settlement website for public copies of participation materials. The board did not record any public objections during these motions.